Subscribe for Updates

March 11, 2016

Minoryx Therapeutics appoints Dr. Khalid Islam as chairman of the board of directors

January 27, 2016

Chiesi Ventures invest in Minoryx

October 14, 2015

Chiesi Ventures invest in rare CNS disease company Minoryx. Minoryx is based in Barcelona, Spain and is developing treatments for X-linked adrenoleukodystrophy and other rare CNS disorders.

Minoryx Therapeutics complete Series A funding of €19.4M ($21.7M)

October 14, 2015

Funds will help company reach clinical validation for lead candidate in X-ALD, a rare neurodegenerative and life-threatening disease